Exploring the challenges with the diverse clinical biomarker requirements.
Advances in precision medicine lead to new trends in immunotherapy.
Overcoming hurdles in a regulated setting.
A breakdown of regulatory guidances and a clear picture of what the IRB needs to see.
Solutions to manage an overwhelming response to a media campaign.
Five characteristics to look for when finding the best-fit site for your study.
Are studies focusing on elderly cancer patients at increased risk for discontinuation due to safety reasons, such as toxicity?
Understand the benefits and challenges of conducting studies in Latin America in addition to some recent changes that could expedite regulatory timelines.
How global site networks can effectively address timeline, budget and data quality concerns, by providing access to multiple experienced sites within a single network, providing cost savings through reduction of the total number of sites used and recruitment of a large volume of patients.
Change the perception of clinical trials by making them less burdensome for patients overall.
|
|
|
|
|
|
|
|
|